Attach great importance to innovative research and clinical application of recombinant human interferon alpha 1b in pediatrics
10.3760/cma.j.issn.2095-428X.2018.18.001
- VernacularTitle:重视重组人干扰素α1b的创新研究和儿科临床应用
- Author:
Yunde HOU
1
;
Guocheng ZHANG
Author Information
1. 中国疾病预防控制中心病毒病预防控制所
- Keywords:
Interferon α1 b;
Child;
Virus;
Inhalation;
Wheezing;
Influenza
- From:
Chinese Journal of Applied Clinical Pediatrics
2018;33(18):1361-1365
- CountryChina
- Language:Chinese
-
Abstract:
As the first class Ⅰ novel genetic engineering medical product in China,recombinant human interferon alpha 1b (IFNα1b) shows unique biological significance and clinical value.Especially in the field of pediatrics,IFNα1 b has been used in the treatment of viral pneumonia,viral hepatitis,bronchiolitis,herpetic angina,hand-footmouth disease and some tumors in children and shown definite efficacy and good safety.It is also used in the prevention and treatment of virus-related wheezing and major infectious diseases,such as influenza.With a greater application prospect,IFNα1b plays an important role in promoting children's health in China.Now,IFNα1b's gene and molecular characteristics,new delivery methods,and the frontier clinical research will be discussed.
